Astromech is using 3.8 billion years of evolutionary history to train AI to predict biological threats, from emerging viruses to drug-resistant superbugs. The company has raised $20 million in new funding, bringing its total to $60 million at a $3.8 billion valuation.
Most computational biology looks at life as it exists today. Astromech wants to predict what happens next. Founded by entrepreneur Ben Lamm and geneticist George Church, the company is building AI models designed to learn from billions of years of evolution and identify where biological systems may be headed—and where they could become dangerous. If the approach works, it could one day help scientists detect emerging pandemics, drug resistance and other biological threats early enough to intervene.
